Efficacy and Safety of Once-Weekly Semaglutide in Adults With Overweight Or Obesity: A Meta-Analysis
Endocrine. 2022;75(3):718–24 doi: 10.1007/s12020-021-02945-1
This publication by Zhong et al describes the first meta-analysis to establish the efficacy and safety of semaglutide in adults with overweight and obesity.